Drug Interactions in Psychopharmacology

Alexanderson, 1969, Steady state plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy, Br Med J, 4, 764, 10.1136/bmj.4.5686.764 Amsterdam, 1984, Cimetidine-induced alterations in desipramine plasma concentrations, Psychopharmacology, 83, 373, 10.1007/BF00428548 Ananth, 1977, A review of combined tricyclic and MAOI therapy, Compr Psychiatry, 18, 221, 10.1016/0010-440X(77)90016-5 Arana, 1988, Carbamazepine-induced reduction of plasma alprazolam concentrations: A clinical case report, J Clin Psychiatry, 49, 448 Aranow, 1989, Elevated antidepressant plasma levels after addition of fluoxetine, Am J Psychiatry, 146, 911, 10.1176/ajp.146.7.911 Austin, 1990, Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients, J Clin Psychiatry, 51, 344 Ayesh, 1988, Influence of quinidine on the pharmacokinetics of nortriptyline and desipramine, Br J Clin Pharmacol, 25, 140 Baastrup, 1976, Adverse reactions in treatment with lithium carbonate and haloperidol, JAMA, 236, 2645, 10.1001/jama.1976.03270240041024 Back, 1990, Pharmacokinetic drug interactions with oral contraceptives, Clin Pharmacokinet, 18, 472, 10.2165/00003088-199018060-00004 Baldessarini, 1990, Drugs and the treatment of psychiatric disorders, 383 Baldessarini, 1991, Clozapine: A novel antipsychotic agent, N Engl J Med, 324, 746, 10.1056/NEJM199103143241107 Baldessarini, 1988, Anticonvulsant cotreatment may increase toxic metabolites of antidepressants and other psychotropic drugs, J Clin Psychopharmacol, 8, 381, 10.1097/00004714-198810000-00026 Batlle, 1985, Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy, N Engl J Med, 312, 408, 10.1056/NEJM198502143120705 Beattie, 1988, Verapamil-induced carbamazepine neurotoxicity: A report of 2 cases, Eur Neurol, 28, 104, 10.1159/000116239 Bergstrom, 1990, Drug interaction between fluoxetine and the tricyclic antidepresants imipramine and desipramine, Pharm Res, 7, S254 Bernstein, 1978, Medical-psychiatric drug interactions, 483 Berridge, 1982, Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands, Biochem J, 206, 587, 10.1042/bj2060587 Binder, 1991, Diltiazem-induced psychosis and a possible diltiazem-lithium interaction, Arch Intern Med, 151, 373, 10.1001/archinte.1991.00400020119023 Blackwell, 1991, Monoamine oxidase inhibitor interactions with other drugs, J Clin Psychopharmacol, 11, 55, 10.1097/00004714-199102000-00009 Boakes, 1973, Sympathomimetic amines and antidepresant agents, BMJ, 2, 114, 10.1136/bmj.2.5858.114-a Brosen, 1989, Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine, Eur J Clin Pharmacol, 37, 155, 10.1007/BF00558224 Brosen, 1991, Fluoxetine and norfluoxetine are potent inhibitors of P450IID6—The source of sparteine/debrisoquine oxidation polymorphism, Br J Clin Pharmacol, 36, 136, 10.1111/j.1365-2125.1991.tb05630.x Brosen, 1992, Pharmacogenetics of tricyclic antidepressants and novel antidepressants: Recent developments, Clin Neuropharmacol, 15, 80A, 10.1097/00002826-199201001-00043 Brown, 1990, Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder, J Clin Psychopharmacol, 10, 359 Brunn, 1988, Lithium clearance and renal tubular sodium handling during acute and long-term nifedipine treatment in essential hypertension, Clin Sei, 75, 609, 10.1042/cs0750609 Byrd, 1977, Lithium carbonate and methyldopa: Apparent interaction in man, Clin Toxicol, 11, 1, 10.3109/15563657708989812 Cater, 1986, The use of Na+ and K+ to to reduce toxicity and side effects from lithium, Med Hypotheses, 20, 359, 10.1016/0306-9877(86)90097-6 Chaudrey, 1983, Lithium and carbamazepine interaction: Possible neurotoxicity, J Clin Psychiatry, 44, 30 Ciraulo, 1990, Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics, J Clin Psychopharmacol, 10, 48, 10.1097/00004714-199002000-00009 Ciraulo, 1990, Fluoxetine drug-drug interactions: II, J Clin Psychopharmacol, 10, 213 Ciraulo, 1990, Question the experts, J Clin Psychopharmacol, 10, 306, 10.1097/00004714-199008000-00026 Ciraulo, 1988, Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers, Clin Pharmacol Ther, 43, 509, 10.1038/clpt.1988.66 Ciraulo, 1989 Cobb, 1991, Possible interaction between clozapine and lorazepam, Am J Psychiatry, 148, 1606, 10.1176/ajp.148.11.1606b Cohen, 1974, Lithium carbonate, haloperidol, and irreversible brain damage, JAMA, 230, 1283, 10.1001/jama.1974.03240090023018 Csemansky, 1985, Using lithium in patients with cardiac and renal disease, Hospital Formulary, 20, 726 Cuthbert, 1969, Cough and cold remedies: A potential danger to patients on monoamine oxidase inhibitors, BMJ, 1, 404, 10.1136/bmj.1.5641.404 Davis, 1974, Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients, J Geriatr Psychiatry, 7, 145 Demers, 1971, Sodium intake and lithium treatment in man, Am J Psychiatry, 128, 100, 10.1176/ajp.128.1.100 Devane, 1990 Devane, 1992, Pharmacokinetics of the selective serotonin reuptake inhibitors, J Clin Psychiatry, 53, 13 Dhillon, 1982, Valproic acid and diazepam interaction in vivo, Br J Clin Pharmacol, 13, 553, 10.1111/j.1365-2125.1982.tb01421.x Douste-Blazy, 1986, Angiotensin converting enzyme inhibitors and lithium treatment, Lancet, 1, 1448, 10.1016/S0140-6736(86)91598-9 Edou, 1983, Interaction medicamenteuse: Clometacin-lithium, Presse Med, 3, 1551 Eichelbaum, 1985, Carbamazepine metabolism in man; induction and pharmacogenetic aspects, Clin Pharmacokinetics, 10, 80, 10.2165/00003088-198510010-00004 Elis, 1967, Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure, BMJ, 2, 75, 10.1136/bmj.2.5544.75 Ereshefsky, 1986, Bioavaüability of psychotropic drugs: Historical perspective and pharmacokinetic overview, J Clin Psychiatry, 47, 6 Ereshefsky, 1991, Thiothixene pharmacokinetic interactions: A study of hepatic enzyme inducers, clearance inhibitors, and demographic variables, J Clin Psychopharmacol, 11, 296, 10.1097/00004714-199110000-00004 Fann, 1974, Chlorpromazine: Effects of antacids on its gastrointestinal absorption, J Clin Pharmacol, 13, 229 Frölich, 1979, Indomethacin increases plasma lithium, BMI, 1, 1115 Gadde, 1990, Diltiazem effect on carbamazepine levels in manic depression, J Clin Psychopharmacol, 10, 378, 10.1097/00004714-199010000-00026 Garbutt, 1987, Potentiation of propoxyphene by phenelzine, Am J Psychiatry, 144, 251, 10.1176/ajp.144.2.251 Glassman, 1981, Cardiovascular effects of therapeutic doses of tricyclic antide pressants, Arch Gen Psychiatry, 38, 815, 10.1001/archpsyc.1981.01780320095011 Godinich, 1990, Renal tubular effects of lithium, Kidney Int, 37, 52 Goff, 1991, Elevation of plasma concentrations of haloperidol after the addition of fluoxetine, Am J Psychiatiy, 148, 790, 10.1176/ajp.148.6.790 Goldstein, 1974 Goodnick, 1991, Pharmacokinetics of second generation antidepressants: Fluoxetine, Psychopharmacol Bull, 27, 503 Goodnick, 1981, Current topics in lithium treatment, Hosp Formul, 16, 1346 Goodnick, 1991, Lithium pharmacokinetics, Psychopharmacol Bull, 27, 475 Goulden, 1987, Clinical valproate toxicity induced by acetylsalicylic acid, Neurology, 37, 1392, 10.1212/WNL.37.8.1392 Gram, 1974, Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man, Am J Psychiatry, 131, 863, 10.1176/ajp.131.8.863 Greenblatt, 1987, Clonazepam pharmacokinetics brain uptake, and receptor interactions, J Clin Psychiatry, 4, 4 Greenblatt DJ, Preskom S, Cotreau M: Fluoxetine impairs clearance of alprazolam but not of clonazepam. Clin Pharmacol, in press Greil, 1985, Lithium dosage in the elderly, J Affective Disord, 9, 1, 10.1016/0165-0327(85)90002-3 Grimsley, 1992, Paroxetine, sertraline, and fluvoxamine: New selective serotonin reuptake inhibitors, Clin Pharmacol, 11, 930 Grimsley, 1991, Increased carbamazepine plasma concentrations after fluoxetine coadministration, Clin Pharmacol Ther, 50, 10, 10.1038/clpt.1991.98 Grohmann, 1989, Adverse effects of clozapine, Psychopharmacology, 99, S101, 10.1007/BF00442571 Guze, 1992 Hanna, 1990, Severe lithium toxicity associated with indapamide therapy, J Clin Psychopharmacol, 10, 379, 10.1097/00004714-199010000-00027 Hansen, 1971, Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man, Clin Pharmacol Ther, 12, 539, 10.1002/cpt1971123539 Hansen, 1990, Interaction of fluoxetine and pentazocine, Am J Psychiatry, 147, 949, 10.1176/ajp.147.7.949 Henhauer, 1984, Cimetidine interaction with imipramine and nortriptyline, Clin Pharmacol Ther, 35, 183, 10.1038/clpt.1984.24 Hoffman, 1971, Antiarrhythmic drugs, 824 Howes, 1983, Reduced steady-state plasma concentrations of indomethacin and chlorpromazine in patients receiving Cimetidine, Eur J Clin Pharmacol, 24, 99, 10.1007/BF00613934 Huang, 1990, Lithium intoxication with coadministration of a loop diuretic, J Clin Psychopharmacol, 10, 228, 10.1097/00004714-199006000-00022 Hurtig, 1974, Lithium toxicity enhanced by diuresis, N Engl J Med, 290, 748, 10.1056/NEJM197403282901324 Jann, 1985, Effects of carbamazepine on haloperidol levels, J Clin Psychopharmacol, 5, 106, 10.1097/00004714-198504000-00010 Jann, 1986, Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance, Psychopharmacology, 90, 468, 10.1007/BF00174062 Janowsky, 1981, Effects of anesthesia on patients taking psychotropic drugs, J Clin Psychopharmacol, 1, 14, 10.1097/00004714-198101000-00004 Jeavons, 1977, Treatment of generalized epilepsies of childhood and adolescence with sodium valproate, Dev Med Child Neurol, 19, 9, 10.1111/j.1469-8749.1977.tb08015.x Jefferson, 1989, Cardiovascular effects and toxicity of anxiolytics and antidepressants, J Clin Psychiatry, 50, 368 Jefferson, 1979, Serum lithium levels and long-term diuretic use, JAMA, 241, 1134, 10.1001/jama.1979.03290370038025 Judd, 1990, Pharmacotherapy of panic disorder, Int Rev Psychiatry, 2, 287, 10.3109/09540269009026609 Kahn, 1990, Change in haloperidol level due to carbamazepine—A complicating factor in combined medication for schizophrenia, J Clin Psychopharmacol, 10, 54, 10.1097/00004714-199002000-00011 Katz, 1991, Raised serum levels of desipramine with the antiarrhythmic propafenone, J Clin Psychiatry, 52, 432 Kerry, 1980, Diuretics are dangerous with lithium, BMJ, 2, 371, 10.1136/bmj.281.6236.371 Khoo, 1980, Influence of phenytoin and phenobarbital on the disposition of a single oral dose of clonezepam, Clin Pharmacol Ther, 28, 368, 10.1038/clpt.1980.175 Kramer, 1986, Carbamazepine-danazol interaction: Its mechanism examined by a stable isotope technique, Ther Drug Monit, 8, 387, 10.1097/00007691-198612000-00001 Lafferman, 1988, Lithium augmentation for treatment-resistant depression in the elderly, J Geriatr Psychiatry Neurol, 1, 49, 10.1177/089198878800100109 Lai, 1978, Time-course of interaction between carbamazepine and clonazepam in man, Clin Pharmacol Ther, 24, 316, 10.1002/cpt1978243316 Leinonen, 1991, Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients, J Clin Psychopharmacol, 11, 313, 10.1097/00004714-199110000-00007 Leishman, 1963, Antagonism of guanethidine by imipramine, Lancet, 1, 112, 10.1016/S0140-6736(63)91123-1 Lemberger, 1985, Fluoxetine: Clinical pharmacology and physiologic disposition, J Clin Psychiatry, 46, 14 Lemberger, 1988, The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam, Clin Pharmacol Ther, 43, 412, 10.1038/clpt.1988.52 Linnoila, 1982, Interaction between antidepressants and perphenazinein psychiatric inpatients, Am J Psychiatry, 139, 1329, 10.1176/ajp.139.10.1329 Linnoila, 1980, Effect of anticonvulsants on plasma haloperidol and thioridazine levels, Am J Psychiatry, 137, 7 Lipinski, 1982, Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients, Am J Psychiatry, 139, 948, 10.1176/ajp.139.7.948 Lock, 1990, Possible adverse drug interactions between fluoxetine and other psychotropics, J Clin Psychopharmacol, 10, 383, 10.1097/00004714-199010000-00031 Loga, 1981, Interaction of chlorpromazine and nortriptyline in patients with schizophrenia, Clin Pharmacokinet, 6, 454, 10.2165/00003088-198106060-00003 MacLoed, 1978, Interaction of disulfiram with benzodiazepines, Clin Pharmacol Ther, 24, 583, 10.1002/cpt1978245583 Mallinger, 1991, Pharmacokinetics of monoamine oxidase inhibitors, Psychopharmacol Bull, 27, 493 Marley, 1984, Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine, or noradrenaline reuptake, J Psychiatr Res, 18, 173, 10.1016/0022-3956(84)90008-6 May, 1985, Serum concentrations of valproic acid: Influence of dose and comedication, Ther Drug Monit, 7, 387, 10.1097/00007691-198512000-00004 McElroy, 1971, Valproate in psychiatric disorders: Literature review and clinical guidelines, J Clin Psychiatry, 50, 23 McGinness, 1990, Avoiding neurotoxicity with lithiumcarbamazepine combinations, Psychopharmacol Bull, 26, 181 McGrath, 1992, Preliminary information about sertraline (Zoloft)—A new, highly selective, serotonin reuptake-inhibitor, Currents in Affective Illness, 11, 5 Miller, 1990, Cigarettes and drug therapy: Pharmacokinetic and pharmacodynamic considerations, Clin Pharmacol, 9, 125 Murray, 1992, P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease, Clin Pharmacokinet, 23, 132, 10.2165/00003088-199223020-00005 Myers, 1990, Plasma and erythrocyte lithium concentrations before and after oral verapamil, Lithium, 1, 49 Nebert, 1991, The P450 superfamily: Update on new sequences, gene mapping and recommended nomenclature, DNA Cell Biol, 10, 1, 10.1089/dna.1991.10.1 Nelson JC: Blood level monitoring of antidepressant and antipsychotic drugs: How useful is it? Psychiatric Times, October 1992, pp 20–26 Nelson, 1980, Neuroleptic effect on desipramine steady-state plasma concentrations, Am J Psychiatry, 137, 1232, 10.1176/ajp.137.10.1232 Nelson, 1982, Major adverse reactions during desipramine treatment, relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics, Arch Gen Psychiatry, 39, 1055, 10.1001/archpsyc.1982.04290090045010 Noveske, 1989, Possible toxicity of combined fluoxetine and lithium, Am J Psychiatry, 146, 1515, 10.1176/ajp.146.11.1515a Ochs, 1981, Diazepam interaction with antituberculous drugs, Clin Pharmacol Ther, 29, 671, 10.1038/clpt.1981.94 Oh, 1977, Furosemide and lithium toxicity, Anaesth Intensive Care, 5, 60, 10.1177/0310057X7700500110 Orr, 1982, Interaction between valproic acid in epileptic children: Serum protein binding and metabolic effects, Clin Pharmacol Ther, 31, 642, 10.1038/clpt.1982.89 Patel, 1980, Phenobarbital-valproic acid interaction, Clin Pharmacol Ther, 27, 515, 10.1038/clpt.1980.72 Patwardhan, 1983, Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines, Hepatology, 3, 248, 10.1002/hep.1840030219 Pearson, 1990, Interaction of fluoxetine with carbamazepine, J Clin Psychiatry, 51, 126 Perei, 1975, Pharmacodynamics of imipramine in depressed patients, Psychopharmacol Bull, 11, 16 Perei, 1969, Inhibitiion of imipramine metabolism by methylphenidate, Federation Proceedings, 28, 418 Perry, 1986, Effects of smoking on nortriptyline plasma concentrations in depressed patients, Ther Drug Monit, 8, 279, 10.1097/00007691-198609000-00007 Perry, 1984, Theophylline precipitated alterations in lithium clearance, Acta Psychiatr Scand, 69, 528, 10.1111/j.1600-0447.1984.tb02527.x Petersen, 1974, Effect of prolonged thiazide treatment on renal lithium clearance, BMJ, 2, 143, 10.1136/bmj.3.5924.143 Phillips, 1986, A pharmacokinetic interaction between erythromycin and triazolam, J Clin Psychopharmacol, 6, 297, 10.1097/00004714-198610000-00008 Pope, 1988, Possible synergism between fluoxetine and lithium in refractory depression, Am J Psychiatry, 145, 1292, 10.1176/ajp.145.10.1292 Post, 1987, Correlates of antimanic response to carbamazepine, Psychiatry Res, 21, 71, 10.1016/0165-1781(87)90064-3 Prakash, 1982, Neurotoxicity with combined administration of lithium with a neuroleptic, Compr Psychiatry, 23, 567, 10.1016/0010-440X(82)90049-9 Preskom, 1982, Toxicity of tricyclic antidepressants: Kinetics, mechanism, intervention: A review, J Clin Psychiatry, 43, 151 Preskom SH, Alderman J, Chung M, et al: Desipramine levels after sertraline or fluoxetine. Presented at the 145th annual meeting of the American Psychiatric Association, May 2–7, 1992, Washington Price, 1986, Neruotoxicity caused by lithium-verapamil synergism, J Clin Pharmacol, 26, 717, 10.1002/j.1552-4604.1986.tb02980.x Ragheb, 1981, Drug interactions in psychiatric practice, Int Pharmacopsychiatry, 16, 92, 10.1159/000468482 Ragheb, 1987, Ibuprofen can increase serum lithium level in lithium-treated patients, J Clin Psychiatry, 48, 161 Ragheb, 1990, The interaction of lithium with phenylbutazone in bipolar affective patients, J Clin Psychopharmacol, 10, 149, 10.1097/00004714-199004000-00030 Ragheb, 1986, Lithium interaction with sulindac and naproxen, J Clin Psychopharmacol, 6, 150, 10.1097/00004714-198606000-00005 Reimann, 1981, Effect of diclofenac on lithium kinetics, Clin Pharmacol Ther, 30, 348, 10.1038/clpt.1981.171 Reimann, 1983, Indomethacin but not aspirin increases plasma lithium ion levels, Arch Gen Psychiatry, 40, 283, 10.1001/archpsyc.1983.01790030053006 Risch, 1981, Interfaces of psychopharmacology and cardiology, pt 1, J Clin Psychiatry, 42, 23 Risch, 1981, Interfaces of psychopharmacology and cardiology, pt 2, J Clin Psychiatry, 42, 47 Rivera-Calimlim, 1978, Effect of lithium on plasma chlorpromazine levels, Clin Pharmacol Ther, 23, 451, 10.1002/cpt1978234451 Rivers, 1970, Possible lethal reaction between Nardil and dextromethorphan, Can Med Assoc J, 103, 85 Rosenblatt, 1992, More about spontaneous postmarketing reports of bupropion-related seizures, Currents in Affective Illness, 11, 18 Saffer, 1983, Furosemide: A safe diuretic during lithium therapy?, J Affective Disord, 5, 289, 10.1016/0165-0327(83)90017-4 Salama, 1989, A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate, Am J Psychiatry, 146, 278, 10.1176/ajp.146.2.278a Schou, 1990, Lithium and treatment-resistant depressions: A review, Lithium, 1, 3 Schwarcz, 1982, The problem of antihypertensive treatment in lithium patients, Compr Psychiatry, 23, 50, 10.1016/0010-440X(82)90008-6 Sellers, 1982, Benzodiazepines and ethanol: Assessment of the effects and consequences of psychotropic drug interactions, J Clin Psychopharmacol, 2, 249, 10.1097/00004714-198208000-00004 Shoaf, 1991, The interaction of ethanol and smoking on the pharmacokinetics and pharmacodynamics of psychotropic medications, Psychopharmacol Bull, 27, 577 Shopsin, 1973, Iodine and lithium-induced hypothyroidism. Documentation of synergism, Am J Med, 55, 695, 10.1016/0002-9343(73)90193-9 Sierles, 1982, Concurrent use of theophylline and lithium in a patient with chronic obstructive lung disease and bipolar disorder, Am J Psychiatry, 139, 117, 10.1176/ajp.139.1.117 Silver, 1986, Elevation of thioridazine levels by propranolol, Am J Psychiatry, 143, 1290, 10.1176/ajp.143.10.1290 Shulman, 1989, Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors, J Clin Psychopharmacol, 9, 397, 10.1097/00004714-198912000-00002 Sovner, 1991, A potential drug interaction between fluoxetine and valproic acid, J Clin Psychopharmacol, 11, 389, 10.1097/00004714-199112000-00018 Spring, 1979, Neurotoxicity with combined use of lithium and thioridazine, J Clin Psychiatry, 40, 135 Steiner, 1986, Toxic reaction following the combined administration of fluoxetine and L-tryptophan: Five case reports, Biol Psychiatry, 21, 1067, 10.1016/0006-3223(86)90287-8 Stembach, 1988, Danger of MAOI therapy after fluoxetine withdrawal, Lancet, 2, 850, 10.1016/S0140-6736(88)92812-7 Stembach, 1991, Fluoxetine-associated potentiation of calcium-channel blockers, J Clin Psychopharmacol, 11, 390, 10.1097/00004714-199112000-00019 Stoeh, 1984, Effect of oral contraceptives on triazolam, temazepam, alprazolam and lorazepam kinetics, Clin Pharmacol Ther, 36, 683, 10.1038/clpt.1984.240 Tate, 1989, Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine, Am J Psychiatry, 146, 399, 10.1176/ajp.146.3.399b Teas, 1981, Toxic delirium resulting from combination antidepressant therapy, Am J Psychiatry, 138, 1127, 10.1176/ajp.138.8.1127a Tesar, 1985, Use of high-dose intravenous haloperiodol in the treatment of agitated cardiac patients, J Clin Psychopharmacol, 5, 344, 10.1097/00004714-198505060-00009 Tesar, 1991, Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder, J Clin Psychiatry, 52, 68 Thomsen, 1968, Renal lithium excretion in man, Am J Physiol, 215, 823, 10.1152/ajplegacy.1968.215.4.823 Tyndale, 1991, Oxidation of reduced haloperidol to haloperidol: Involvement of human P450IID6, Br J Pharmacol, 31, 655, 10.1111/j.1365-2125.1991.tb05588.x Van Spanning, 1973, The interference of tricyclic antidepressants with the central hypotensive effect of clonidine, Eur J Pharmacol, 24, 402, 10.1016/0014-2999(73)90169-6 Vaughan, 1988, Interaction of fluoxetine with tricyclic antidepressants, Am J Psychiatry, 145, 1478, 10.1176/ajp.145.11.1478b Vigran, 1964, Dangerous potentiation of meperidine hydrochloride by pargyline hydrochloride, JAMA, 187, 953, 10.1001/jama.1964.03060250071021 von Ammon Cavanaugh, 1990, Drug-drug interactions of fluoxetine with tricyclics, Psychosomatics, 31, 273, 10.1016/S0033-3182(90)72163-9 Walbridge, 1985, An interaction between lithium carbonate and piroxicam presenting as lithium toxicity, Br J Psychiatry, 147, 206, 10.1192/bjp.147.2.206 Walker, 1980, Lithium-methyldopa interactions in normal subjects, Drug Intelligence and Clinical Pharmacy, 14, 638 Wames, 1976, Adynamic ileus during p>sychoactive medication, Can Med Assoc J, 96, 1112 Weilburg, 1989, Fluoxetine added to non-MAOI antidepressants converts non-responders to responders: A preliminary report, J Clin Psychiatry, 50, 447 Weinrauch, 1984, Decreased serum lithium during verapamil therapy, Am Heart J, 108, 1378, 10.1016/0002-8703(84)90776-2 White, 1986, Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril, Arch Intern Med, 146, 1833, 10.1001/archinte.1986.00360210229035 Wilder, 1978, Valproic acid: Interaction with other anticonvulsant drugs, Neurology, 28, 892, 10.1212/WNL.28.9.892 Wong, 1983, Effect of erythromycin on carbamazepine kinetics, Clin Pharmacol Ther, 33, 460, 10.1038/clpt.1983.62 Wright, 1982, Isoniazid-induced carbamazepine toxicity and vice versa: a double drug interaction, N Engl J Med, 307, 1325, 10.1056/NEJM198211183072107